Capricor Therapeutics Inc. (NASDAQ: CAPR) Stock Information | RedChip

Capricor Therapeutics Inc. (NASDAQ: CAPR) Listen to this Section


$3.89
-0.0100 ( -0.26% ) 139.5K

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Market Data


Open


$3.89

Previous close


$3.90

Volume


139.5K

Market cap


$126.58M

Day range


$3.85 - $4.08

52 week range


$2.68 - $8.22

Insider Ownership Transactions

Total Amount Purchased: -135,748.00 | $ -528,059.72

Date Type Amount Purchased Purchaser
2023-09-06 Sale -115000.00 Kelliher Mike
2023-08-16 Sale -20748.00 Litvack Frank

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
8-k 8K-related 14 Dec 11, 2023
8-k 8K-related 14 Nov 14, 2023
10-q Quarterly Reports 54 Nov 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.